Effect of granulocyte macrophage-colony stimulating factor (GM-CSF) on 5-FU-induced ulcerative mucositis in hamster buccal pouches

Exp Toxicol Pathol. 2006 Mar;57(4):321-8. doi: 10.1016/j.etp.2005.09.006. Epub 2006 Jan 18.

Abstract

The present study was performed to investigate the protective effects of granulocyte macrophage-colony stimulating factor (GM-CSF) against ulcerative mucositis in hamster buccal pouch. GM-CSF was topically administered to the buccal pouches of hamsters with two different doses of 5 and 20 microg/ml. The treatment of GM-CSF led to rapid healing effects in gross and histopathological findings. It decreased expression of pro-inflammatory cytokine mRNA levels in the mucosal tissue of buccal pouches. Also GM-CSF-treated animals showed high numbers of Ki-67 positive cells in basal cell layer. These results suggest that GM-CSF provided excellent healing effects to ulcerative mucositis in the buccal pouch of hamster.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Animals
  • Anti-Ulcer Agents / therapeutic use*
  • Biomarkers / metabolism
  • Cricetinae
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Fluorouracil / toxicity*
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
  • Male
  • Mesocricetus
  • Mouth Mucosa / drug effects*
  • Mouth Mucosa / metabolism
  • Mouth Mucosa / pathology
  • Oral Ulcer / chemically induced
  • Oral Ulcer / drug therapy*
  • Oral Ulcer / pathology
  • Recombinant Proteins
  • Stomatitis / chemically induced
  • Stomatitis / drug therapy*
  • Stomatitis / pathology

Substances

  • Anti-Ulcer Agents
  • Biomarkers
  • Recombinant Proteins
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Fluorouracil